Treatment-independent miRNA signature in blood of wilms tumor patients
- Equal contributors
1 Department of Human Genetics, Saarland University, 66421 Homburg/Saar, Germany
2 Department of Pediatric Oncology and Hematology, Medical School, Saarland University, 66421 Homburg, Germany
3 febit group, 69120 Heidelberg, Germany
4 Developmental Biochemistry, Biocenter, University of Würzburg, 97074 Würzburg, Germany
5 Center for Bioinformatics, Saarland University, 66041 Saarbrücken, Germany
BMC Genomics 2012, 13:379 doi:10.1186/1471-2164-13-379Published: 7 August 2012
Additional file 1:
Table S1. Patient data of Wilms tumor samples. Detailed information about the diagnosis of Wilms tumor patients. Table S2. Data of control samples. Information about age and sex of control samples.
Format: DOC Size: 98KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Table S1. Overview of significantly deregulated miRNAs in Wilms before therapy compared to normal controls. The 176 deregulated miRNAs including their fold change, p-values, and AUC values of the comparison Wims before therapy versus normal controls.
Format: XLS Size: 74KB Download file
This file can be viewed with: Microsoft Excel Viewer